Key terms

About HSIC

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest HSIC news

Apr 10 4:07pm ET Henry Schein names three new members to Executive Management Committee Apr 04 6:33am ET Henry Schein completes acquisition of majority interest in TriMed Mar 04 10:53am ET Henry Schein management to meet with Oppenheimer Feb 28 9:20am ET Wall Street Analysts Are Bullish on Top Healthcare Picks Feb 28 9:06am ET Henry Schein price target raised to $90 from $82 at Barrington Feb 28 8:10am ET Henry Schein price target raised to $75 from $65 at BofA Feb 28 6:56am ET Henry Schein price target raised to $83 from $76 at Baird Feb 28 5:49am ET Henry Schein Stock Faces Headwinds: Sell Rating Affirmed Amidst Growth and Revenue Challenges Feb 27 10:55pm ET Goldman Sachs Sticks to Its Hold Rating for Henry Schein (HSIC) Feb 27 6:01am ET Henry Schein sees FY24 adjusted EPS $5.00-$5.16, consensus $5.11 Feb 27 6:00am ET Henry Schein reports Q4 adjusted EPS 66c, consensus 70c Feb 26 8:25pm ET Notable companies reporting before tomorrow’s open Feb 26 1:14pm ET Notable companies reporting before tomorrow’s open Feb 26 7:31am ET Henry Schein price target raised to $86 from $78 at Piper Sandler Feb 26 6:30am ET Henry Schein initiated with a Market Perform at Leerink Feb 21 8:02am ET Stifel Nicolaus upgrades Henry Schein (HSIC) to a Buy Jan 26 7:38am ET Henry Schein price target raised to $80 from $75 at Stifel Jan 22 12:40pm ET Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), RegenXBio (RGNX) and Henry Schein (HSIC) Jan 22 12:21pm ET Wall Street Analysts Are Bullish on Top Healthcare Picks

No recent news articles are available for HSIC

No recent press releases are available for HSIC

HSIC Financials

1-year income & revenue

Key terms

HSIC Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

HSIC Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms